Increased Burden of Cerebral Small Vessel Disease in Patients With Type 2 Diabetes and Retinopathy

Autor/a

Sanahuja Montesinos, Jordi

Alonso, Núria

Diez, Javier

Ortega, Emilio

Rubinat, Esther

Traveset Maeso, Alicia

Alcubierre Calvo, Núria

Betriu i Bars, M. Àngels

Castelblanco Echavarría, Esmeralda

Hernández García, Marta

Purroy Garcia, Francisco

Arcidiacono, Maria V.

Jurjo Campo, Carmen

Fernández i Giráldez, Elvira

Puig-Domingo, Manuel

Groop, Per-Henrik

Mauricio Puente, Dídac

Fecha de publicación

2018-06-15T09:45:13Z

2018-06-15T09:45:13Z

2016-06-08

2018-06-15T09:45:13Z



Resumen

OBJECTIVE We sought to examine the presence and severity of brain small vessel disease (SVD) in patients with type 2 diabetes and diabetic retinopathy (DR) compared with those without DR. RESEARCH DESIGN AND METHODS We evaluated 312 patients with type 2 diabetes without previous cardiovascular disease (men 51%; mean age 57 years; age range 40–75 years); 153 patients (49%) had DR. MRI was performed to evaluate the presence and severity (age-related white matter changes scale) of white matter lesions (WMLs) and lacunes, and transcranial Doppler ultrasound was used to measure the Gosling pulsatility index (PI) of the middle cerebral artery (MCA). RESULTS The prevalence of lesions of cerebral SVD (WML and/or lacunes) was higher in patients with DR (40.2% vs. 30.1% without DR, P = 0.04). Age (P < 0.01) and systolic blood pressure (P = 0.02) were associated with the presence of SVD. The severity of SVD was associated with age and the presence of DR (P < 0.01 and P = 0.01, respectively). Patients with DR showed a higher MCA PI compared with those without DR (P < 0.01). Age, systolic and diastolic blood pressure, and retinopathy and its severity were associated with an increased MCA PI (P < 0.01 for all variables). A positive correlation was found between MCA PI values and the presence and severity of SVD (P < 0.01 for both variables). CONCLUSIONS Patients with type 2 diabetes who have DR have an increased burden of cerebral SVD compared with those without DR. Our findings suggest that the brain is a target organ for microangiopathy, similar to other classic target organs, like the retina.


This study was supported by grant PS09/01035 from Instituto de Salud Carlos III, Ministry of Economy and Competitiveness, Spain, and CIBERDEM is an initiative from Instituto de Salud Carlos III (Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional).

Tipo de documento

Artículo
acceptedVersion

Lengua

Inglés

Materias y palabras clave

Malalties cerebrovasculars; Diabetis no-insulinodependent; Retina -- Malalties

Publicado por

American Diabetes Association

Documentos relacionados

info:eu-repo/grantAgreement/MICINN//PS09%2F01035/ES/ESTUDIO EXPLORATORIO DE ORGANOS DIANA NO CLASICOS DE LA MICROANGIOPATIA DIABETICA/

Versió postprint del document publicat a https://doi.org/10.2337/dc15-2671

Diabetes Care, 2016, vol. 39, núm. 9, p. 1614-1620

Derechos

(c) American Diabetes Association, 2016

Este ítem aparece en la(s) siguiente(s) colección(ones)